Pre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study

被引:0
|
作者
Batty, G. David [1 ]
Gale, Catharine R. [2 ]
机构
[1] UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England
[2] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England
来源
CLINICAL EPIDEMIOLOGY | 2021年 / 13卷
基金
英国医学研究理事会;
关键词
risk factors; amyotrophic lateral sclerosis; cohort study; UK Biobank; ADULT HEIGHT; MORTALITY; EPIDEMIOLOGY; NEUROTICISM; DEATH; ALS; METAANALYSIS; ASSOCIATION; DEMENTIA; HEALTH;
D O I
10.2147/CLEP.S32952131
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: In the absence of effective treatments for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder with high case fatality, there is a clear need to identify its primary risk factors. Methods: UK Biobank is a prospective cohort study in which baseline data were captured between 2006 and 2010 in 502,649 participants aged 37 to 73 years. Follow-up for ALS hospitalisations and death was made via national registries. Results: Eleven years of event surveillance gave rise to 301 hospitalisations and 279 deaths due to ALS. After adjustment for selected confounding factors, being older (hazard ratio per 10 year increase; 95% confidence interval: 1.92; 1.58, 2.33) and male (1.37; 1.00, 1.87) were associated with elevated rates of hospitalisation for ALS. Similar effects were apparent when death ascribed to the disorder was the outcome of interest. Of the remaining 23 social, biological, and behavioural risk indices, however, there was only a suggestion that taller people experienced an increased risk of hospitalisation (per SD increase: 1.31; 1.09, 1.59). Conclusion: In the present, large-scale study, other than well known associations, we did not find convincing evidence of links with ALS for other risk indices.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 50 条
  • [1] The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis
    D'Ovidio, F.
    d'Errico, A.
    Carna, P.
    Calvo, A.
    Costa, G.
    Chio, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (01) : 164 - 170
  • [2] Pre-morbid Laboratory Tests, Diseases, and Medications in Amyotrophic Lateral Sclerosis in Israel
    Abraham, Alon
    Abramovich, Beatrice
    Banon, Tamar
    Weil, Clara
    Chodick, Gabriel
    Birman, Nurit
    Fainmesser, Yaara
    Drory, Vivian E.
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (09): : 617 - 621
  • [3] PRE-MORBID TYPE 2 DIABETES MELLITUS AS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS
    Jawaid, Ali
    Schulz, Paul E.
    [J]. MUSCLE & NERVE, 2015, 52 (04) : 690 - +
  • [4] Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
    Paganoni, Sabrina
    Hyman, Theodore
    Shui, Amy
    Allred, Peggy
    Harms, Matthew
    Liu, Jingxia
    Maragakis, Nicholas
    Schoenfeld, David
    Yu, Hong
    Atassi, Nazem
    Cudkowicz, Merit
    Miller, Timothy M.
    [J]. MUSCLE & NERVE, 2015, 52 (03) : 339 - 343
  • [5] PRE-MORBID TYPE 2 DIABETES MELLITUS AS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS REPLY
    Paganoni, Sabrina
    Schoenfeld, David
    Shui, Amy
    Cudkowicz, Merit
    Miller, Timothy M.
    [J]. MUSCLE & NERVE, 2015, 52 (04) : 691 - 691
  • [6] Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study
    Valentina Gallo
    Nicola Vanacore
    H. Bas Bueno-de-Mesquita
    Roel Vermeulen
    Carol Brayne
    Neil Pearce
    Petra A. Wark
    Heather A. Ward
    Pietro Ferrari
    Mazda Jenab
    Peter M. Andersen
    Patrik Wennberg
    Nicholas Wareham
    Verena Katzke
    Rudolf Kaaks
    Elisabete Weiderpass
    Petra H. Peeters
    Amalia Mattiello
    Valeria Pala
    Aurelio Barricante
    Maria-Dolores Chirlaque
    Noémie Travier
    Ruth C. Travis
    Maria-Jose Sanchez
    Hélène Pessah-Rasmussen
    Jesper Petersson
    Anne Tjønneland
    Rosario Tumino
    Jose Ramon Quiros
    Antonia Trichopoulou
    Andreas Kyrozis
    Despoina Oikonomidou
    Giovanna Masala
    Carlotta Sacerdote
    Larraitz Arriola
    Heiner Boeing
    Matthaeus Vigl
    Francoise Claver-Chapelon
    Lefkos Middleton
    Elio Riboli
    Paolo Vineis
    [J]. European Journal of Epidemiology, 2016, 31 : 255 - 266
  • [7] Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study
    Gallo, Valentina
    Vanacore, Nicola
    Bueno-de-Mesquita, H. Bas
    Vermeulen, Roel
    Brayne, Carol
    Pearce, Neil
    Wark, Petra A.
    Ward, Heather A.
    Ferrari, Pietro
    Jenab, Mazda
    Andersen, Peter M.
    Wennberg, Patrik
    Wareham, Nicholas
    Katzke, Verena
    Kaaks, Rudolf
    Weiderpass, Elisabete
    Peeters, Petra H.
    Mattiello, Amalia
    Pala, Valeria
    Barricante, Aurelio
    Chirlaque, Maria-Dolores
    Travier, Noemie
    Travis, Ruth C.
    Sanchez, Maria-Jose
    Pessah-Rasmussen, Helene
    Petersson, Jesper
    Tjonneland, Anne
    Tumino, Rosario
    Ramon Quiros, Jose
    Trichopoulou, Antonia
    Kyrozis, Andreas
    Oikonomidou, Despoina
    Masala, Giovanna
    Sacerdote, Carlotta
    Arriola, Larraitz
    Boeing, Heiner
    Vigl, Matthaeus
    Claver-Chapelon, Francoise
    Middleton, Lefkos
    Riboli, Elio
    Vineis, Paolo
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2016, 31 (03) : 255 - 266
  • [8] Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis - A prospective cohort study
    Fang, Fang
    Bellocco, Rino
    Hernan, Miguel A.
    Ye, Weimin
    [J]. NEUROEPIDEMIOLOGY, 2006, 27 (04) : 217 - 221
  • [9] Systemic inflammation and subsequent risk of amyotrophic lateral sclerosis: Prospective cohort study
    Batty, G. David
    Kivima, Mika
    Frank, Philipp
    Gale, Catharine R.
    Wright, Liam
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2023, 114 : 46 - 51
  • [10] Amyotrophic Lateral Sclerosis, genetics and ambient risk factors, a cohort epidemiologic study
    Conde, B.
    Canedo, P.
    Martins, N.
    Winck, J. C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 960 - 960